Key Takeaways Retatrutide has no official price: it's an investigational drug in Phase 3 clinical trials (Eli Lilly's TRIUMPH program) and is not FDA-approved Research peptide retatrutide costs roughly $40$120 per 5mg vial , translating to approximately $150$500/month at clinical-level doses Compounded retatrutide from telehealth or compounding pharmacies runs approximately $200$500/month Projected commercial pricing at launch (~20272028) is estimated at $1,000$1,500/month , benchmarked against Mounjaro/Zepbound Clinical trial enrollment provides free access to retatrutide
Tip: The glucagon receptor component may cause slightly higher rates of nausea compared to semaglutide or tirzepatide at similar efficacy levels
Funding The authors are grateful to the National Key Research and Development Program of China (2022YFD1300701, 2019YFE0115000) and the China Agriculture Research System of MOF and MARA (CARS-41)
Topiramate is a carbonic anhydrase inhibitor, which means it blocks a specific enzyme in the body
Yaneva M, Handjieva-Darlenska T, Kazandjieva J, Darlenski R
Likewise, sometimes youll need to give your body more time to adjust when you shift between dosages or start the medication for the first time